Clever Leaves Holdings Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Clever Leaves Holdings.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 20.9% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Even With A 59% Surge, Cautious Investors Are Not Rewarding Clever Leaves Holdings Inc.'s (NASDAQ:CLVR) Performance Completely
Feb 26
There's No Escaping Clever Leaves Holdings Inc.'s (NASDAQ:CLVR) Muted Revenues
Jun 24Clever Leaves partners with House of Kush for international expansion
Sep 21Clever Leaves reports Q2 results
Aug 11Everyone Says Sell Your Cannabis Stocks! I See It Differently (Podcast Transcript)
Jul 26Clever Leaves exports cannabis to Israel partner Intercure
Jul 18Clever Leaves expands partnership with Cantourage
Jul 11Clever Leaves Remains A Hold As It Ramps Up German Medical Cannabis And Colombian Exports
Jun 10Clever Leaves: New Management Needs To Nail Cannabis Distribution, Not Just Production
Mar 28Clever Leaves Looks Overvalued Based On Fundamentals
Jan 12Clever Leaves CEO Kyle Detwiler - Multi-National Cannabis Wholesaler (Video)
Jul 08Clever Leaves Holdings: A Smart Way To Gain Exposure To Cannabis Market
Jun 27Clever Leaves dispatches commercial flower shipment to Australia through IDT Australia
Jun 21Clever Leaves trades higher on joining Russell Microcap Index
Jun 14Clever Leaves Holdings (CLVR) Presents At 2021 ICR Conference - Slideshow
Jan 13Clever Leaves inks multi-year partnership with Entourage Phytolab
Jan 12Clever Leaves: Not The Ideal Cannabis Position
Jan 06In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Clever Leaves Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 17 | -20 | -12 | -12 | N/A |
| 9/30/2023 | 19 | -51 | -15 | -15 | N/A |
| 6/30/2023 | 18 | -62 | -18 | -18 | N/A |
| 3/31/2023 | 17 | -56 | -25 | -25 | N/A |
| 12/31/2022 | 16 | -38 | -30 | -29 | N/A |
| 9/30/2022 | 16 | -54 | -35 | -32 | N/A |
| 6/30/2022 | 17 | -35 | -40 | -35 | N/A |
| 3/31/2022 | 17 | -46 | -42 | -36 | N/A |
| 12/31/2021 | 15 | -46 | -44 | -36 | N/A |
| 9/30/2021 | 15 | -35 | -38 | -32 | N/A |
| 6/30/2021 | 14 | -42 | -31 | -27 | N/A |
| 3/31/2021 | 13 | -41 | -30 | -25 | N/A |
| 12/31/2020 | 12 | -36 | -26 | -22 | N/A |
| 9/30/2020 | 11 | -39 | -37 | -26 | N/A |
| 6/30/2020 | 11 | -44 | -52 | -34 | N/A |
| 3/31/2020 | 11 | -43 | -61 | -43 | N/A |
| 12/31/2019 | 8 | -40 | -56 | -37 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if CLVR's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if CLVR's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if CLVR's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if CLVR's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if CLVR's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CLVR's Return on Equity is forecast to be high in 3 years time